chrisvoncsefalvay/vaers-outcomes huggingface dataset:
SHORTNESS OF BREATH; CHEST PINCHING; FAST HEART BEAT; RASHES HAD REDNESS; RASHES AS ITCHY; RASHES ON CHEST AND BACK AS PAINFUL; EASILY GOT TIRED; FELT HEART WAS CONGESTED; COUGH; LITTLE BIT OF HEADACHE; This spontaneous report received from a patient concerned a 48 year old male. The patient's weight was 150 pounds, and height was 170 centimeters. The patient's past medical history included low platelet, and bypass surgery, and concurrent conditions included rashes allergy, non drinker, and non-smoker, and other pre-existing medical conditions included the patient had no history of drug abuse or illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1808978, and expiry: UNKNOWN) dose was not reported, administered on 31-MAR-2021 for prophylactic vaccination. Concomitant medications included acetylsalicylic acid for low platelet. On 31-MAR-2021, the subject experienced little bit of headache. On APR-2021, the subject experienced felt heart was congested. On APR-2021, the subject experienced cough. On 12-APR-2021, the subject experienced shortness of breath. On 12-APR-2021, the subject experienced chest pinching. On 12-APR-2021, the subject experienced fast heart beat. On 12-APR-2021, the subject experienced rashes had redness. On 12-APR-2021, the subject experienced rashes as itchy. On 12-APR-2021, the subject experienced rashes on chest and back as painful. On 12-APR-2021, the subject experienced easily got tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from little bit of headache on 01-APR-2021, had not recovered from shortness of breath, chest pinching, fast heart beat, rashes on chest and back as painful, easily got tired, rashes as itchy, and rashes had redness, and the outcome of felt heart was congested and cough was not reported. This report was non-serious.; Sender's Comments: V0-  Medical Assessment Comment not required as per standard procedure as the case assessed as non-serious.
Received immunizations in morning of 7/24/06, right upper arm became swollen, red and hot to touch in evening of 7/24/06, ice applied, child given tylenol and ibuprophen on alternating schedule. Brought to health dept. on 7/26/06 at 1PM, site remains red and swollen and hot to touch.  No other symptoms reported by mom. Mom reports she did not seek medical care for child.
Information has been received from a certified medical assistant concerning a patient of unknown age. On 10-MAR-2016 the patient was vaccinated with an expired dose of ZOSTAVAX (lot number was L000461, expiry date 08-MAR-2016) with no known temperature excursions. The reporter was not sure if the dose was administered but it might have been. No adverse effects reported. Additional information has been requested.
Injection was given at 8:15 am.  Patient returned thirty minutes later complaining of difficulty breathing, throat tightness, anxiety, uticaria on right flank.
Approx 10 mins post vax, PT became itchy, drooling, red rash all over body.
COVID 19; COVID 19; This is a spontaneous report received from a contactable reporter(s) (Other HCP). A 62-year-old female patient (not pregnant) received BNT162b2 (BNT162B2, Vaccine brand unknown, Vaccine lot unknown and Vaccine dose number unknown: False), on 14Apr2022 as dose 4 (booster), single (Lot number: FJ4989) at the age of 62 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Type II DM" (unspecified if ongoing); "Hypothyroidism" (unspecified if ongoing); "asthma" (unspecified if ongoing); "hyperlipidemia" (unspecified if ongoing); "HTN" (unspecified if ongoing); "GERD" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19". Therapeutic measures were taken as a result of drug ineffective, covid-19. Anti-viral details: Product: COVID 19 Treatment. Other medication details: Other medication in 2weeks product: Paxlovid EUA, Other medication in 2weeks start date: 26Jun2022, Other medication in 2weeks stop date: 01Jul2022, Other medication in 2weeks administrator route: oral, Adverse event: COVID-19 Rebound. Adverse event start date: 06Jul2022. AE treatment: Supportive care, prescription med. Known allergies: No.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on available information, a possible contributory role of BNT162B2 vaccine cannot be excluded for the reported events of COVID-19  and Drug ineffective
Patient was given vaccine with several people (8+) watching the administration. Patient had received vaccine in past without issue. Shortly after administration, patient left and returned complaining of lightheadedness, some chest tightness, and flushing. Patient was able to speak and swallow and was not in respiratory distress. Patient was given oral diphenhydramine 50 mg and closely monitored. After 5-10 minutes, patient reported feeling cold but better. Over 35-40 minutes, patient reported feeling better and was no longer flushed. She and S/O left. Later that evening, patient had chills, fevers, and vomiting. She was in hospital for 2 days. Patient feels much better.
This spontaneous report was received from an nurse practitioner and refers to a 69 year old female patient. There was no information regarding the patient's medical history, concomitant medication, drug reactions and allergies provided. On 28-FEB-2018, the patient was vaccinated with PNEUMOVAX 23, first dose for prophylaxis (lot# M037533, expiration date 17-MAY-2018). On 23-SEP-2018, the patient received second dose of PNEUMOVAX 23 (lot# N014946, expiration date: 01-FEB-2019). Both vaccines were properly stored prior to administration. No adverse effects were reported.
Severe flu like symptoms. Most concerningly I had 4/10 L chest and L scapular pain for 48+ hr once symptoms starting kicking in. Also the lymph node in my Left armpit (vaccine side) grew into the size of a baseball for over 2 days as well.
Starting having lost of breath, like catch air, it hurt my ribs espeachilly when using the restroom. Had to go to the hospital , ER, and doctor office various times for different events including passing out.  3/11/2022  was sent to an out pt. then sent by ambulance to the the hospital  and admitted until 3/13/2022. Diagnosed with Myocarditis Then back on the 3/14/2022 and rediagnosised me for pericarditis.   On the  3/17/2022  I saw Dr.  4/1/2022  saw the cardiologist  Dr. and she told me my heart was blocked and I was only getting 30 bpm and I was  rushed and transferred to where Dr. rushed me in for surgery for a pacemaker.
The dose for the Moderna vaccine is .5 mL. The patient inadvertently received an extra 0.01 to 0.02 mL. The manufacturer instructed us to contact the patient to inform them that the increased dosage could potentially lead to side effects that could be local or systemic. The patient experienced migraine for a week cough and runny nose.
10 minutes after administration, client reported feeling strange, describing lightheaded and short of breath. Appeared diaphoretic.  Vital signs 154/100, RR 22, HR 82. Client used albuterol rescue inhaler, reported some improvement of breathing.  Given snack and water, rested five more minutes, vital signs 141/92, hr 72, rt 20.  Encouraged pursed lip breathing and to lean forward to ease respiratory effort. Client stated she needed to catch her bus going home and was advised to contact her doctor if symptoms persisted or seek emergency care if worsening of respiration not eased by her prescribed meds.  Client had just seen her doctor, agreed to call the office as needed. Follow up phone call at 3:30 PM, Mailbox full could not leave a voice message
Information has been received from a physician concerning her 12 year old daughter who on an unspecified date was vaccinated with a 0.5 ml dose of Varivax. On 26-JUL-2006 the patient developed possible breakthrough varicella. Unspecified medical attention was sought. At the time of the report the patient had not recovered. No further information was provided. There was no product quality complaint involved. Additional information has been requested.
At about midday my arms started getting warm and itchy, when I looked at the spot I was itching I noticed that I had welts. This moved up my arms and onto my neck, face, cheeks, and eyes. This led me to go to urgent care. This has happened for all my other doses. I did see an allergist after getting the second shot, the allergist said that if I had hives as a kid and they can lay dormant and the shot may have caused them to act up.
Patient had nausea, vomiting, and abdominal pain on 8/31. On 9/1 she had respiratory distress and presented to the hospital. She was tested for COVID on 9/1 and was positive. She is on 2L of Oxygen.
Vaccine given 6 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given 6 days post expiry) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 011L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment medication was reported.   This case was linked to MOD-2021-395985 (Patient Link).
Information has been received from a certified medical assistant concerning a 21 year old female with amoxicillin allergy and no pertinent medical history, who in the years 2004 and 2005 was vaccinated with 3 doses of the GARDASIL series. There was no concomitant medication. The medical assistant reported that the patient did not receive the vaccine at her office. In February 2009, the patient had positive atypical cells of undetermined significance PAP smear and was diagnosed positive for HPV. The patient was seen at the physician's office. On 28-APR-2009, the patient had a colposcopy with endocervical curettage. At the time of reporting the patient had not recovered from the event. Additional information has been requested.
lowrubella titer; This spontaneous report has been received from a physician referring to an approximately 63 years old male patient. The patient's concurrent condition, medical history and concomitant therapy information was not provided.   On an unknown date, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live manufacturer unknown (strength, dose, frequency, route, lot # and expiration date were not reported) for prophylaxis.            The patient was serologically tested in recent past (week of 13-MAY-2019) based on recent measles outbreak circumstances. The titer results revealed low rubella titers and didn't show low measles titer. No treatment was given for the event. On an unspecified date in May 2019, the patient recovered from the event.  The causality between the event and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live manufacturer unknown was not provided.   This is one of several reports received from the same reporter. ; Sender's Comments:  US-009507513-1905USA008985: US-009507513-1906USA004734:
This spontaneous report has been received from a field employee referring to multiple unspecified patients of unknown age and gender. On multiple unspecified dates, the multiple unspecified patients were vaccinated with doses of ZOSTAVAX (strength, route, indication, Lot# and expiration date were not provided). The same multiple unspecified patients returned to the office because they had "developed shingles" on unspecified dates "within the last few weeks after the administration of ZOSTAVAX". It was also reported that the number of patients who developed shingles after the administration of ZOSTAVAX was increasing. The outcome of the adverse events was not reported. The reporter's causality was not provided. Additional information has been requested.
J&J BOOSTER VACCINE, EXTREME ITCHING AND HIVES FOR OVER A MONTH.  DIFFICULT BREATHING
Severe migraine for 8 hours with vomiting, followed by headaches for 3 weeks (still have), body aches, fatigue & chills all started @ 9:00pm  the day of vaccination (11 hours after).  I still suffer from headaches, body aches, especially lower back, joint pain, hot flashes, insomnia, heart palpitations, fatigue & difficulty concentrating.
the arm got red and splotchy and had a minor rash and also some infusion site pain; the arm got red and splotchy and had a minor rash and also some infusion site pain; the arm got red and splotchy and had a minor rash and also some infusion site pain; he was incredibly fatigued; This spontaneous report was received from a consumer via a company representative referring to a male patient of unknown age. Information about medical history, concurrent conditions and concomitant therapies was not provided.       On 15-OCT-2020, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), influenza virus vaccine (unspecified) and diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid (strength, dose, route, lot # and expiration date were not reported) for prophylaxis.      On the same day, the patient got red and splotchy, a minor rash, and some infusion site pain in the arm that he received pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) and influenza virus vaccine (unspecified), and he was also incredibly fatigued the rest of that day. The outcome of the events was unknown. The causality assessment was not reported.
Narrative: COVID infection following COVID vaccine series 01/28, Pfizer, dose #1 (NON-FACILTY) 02/18, Pfizer, dose #2 (NON-FACILITY) 09/01 pt cc: fatigue, rhinorrhea exposure: unknown 09/23 COVID swab, result: detected
pt recvd 3 doses of Engerix-B vax; anti-HBS neg; pt recvd 4th dose of Engerix-B anti-HBS again neg; sustained lifting injury on the job; refuses any more Hep B vax; will be placed on permanent disability (from work);
Pt received a dose that was beyond use date of the vial. Vial was stored in the refrigerator and was administered past the expiration. Pt had no adverse event and was recommended to be given another dose without interval based on CDC guidelines.
LIGHTHEADED FOR 15 MINUTES AFTER VACCINATION; FOREHEAD WAS CLAMMY; This spontaneous report received from a health care professional concerned a 55 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: gout, and rheumatoid arthritis, and other pre-existing medical conditions included: patient did not have allergies to medications, food or other products. The patient did not have any adverse event following any previous vaccine. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 211A21A and expiry: UNKNOWN) dose was not reported, administered on 21-SEP-2021 10:45 for prophylactic vaccination.  Concomitant medications included allopurinol.  On 21-SEP-2021, the patient experienced lightheaded for 15 minutes after vaccination. On 21-SEP-2021, the patient experienced forehead was clammy. Laboratory data included: Blood glucose (NR: not provided) 132, Blood pressure (NR: not provided) normal, Heart rate (NR: not provided) elevated, and Vital signs measurement (NR: not provided) Stable. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from lightheaded for 15 minutes after vaccination, and forehead was clammy on 21-SEP-2021. This report was non-serious.
Mom called three days after injection was given to report pt. had "itchy, red area, 6 in long, raised, warm". Denied SOB, itching or swelling around lips or mouth. Pt was given BENADRYL by mom, used ice at site.
Before going to bed i had a searing pain above my right eye, above the temple area. i took more Tylenol and went to bed. I awoke to find my right eye bloody. Blood vessels had burst. Later that day I had the headache and flu symptoms that lingered for three days. On the fifth day following the shot, my left arm started to burn and itch. it swelled a great deal and was hot to the touch. i contacted the pharmacist and he said i had "Covid" arm. The swelling, itching, hot rash was approximately four inches in circumference. It lingered for four days. About the time the Covid arm showed up, I developed vertigo in my right ear. The vertigo is still debilitating at times. I have done E[ley maneuvers and Reiki to rid myself of the problem and it is getting somewhat better. I did not see my regular phsysician, because she would not have asserted the shot had anything to do with my issues. She is all about the shot regardless of past infection and natural antibodies, which I have. I am one of the first documented Covid cases, and have regularly had my antibodies tested through Dr. In addition to the vertigo, I have brain fog. I cannot remember words.
Husband was driving, he got his vaccine at the same time, I was on passenger side. Within  one minute of injection, my head felt really funny, underside of lower arm started itching (the itching went away within a minute or so), chest tightened and felt light headed. Got out of vehicle for some fresh air, was told if dizzy, sit down.  Got back in vehicle and blasted AC and leaned into vent to breathe.  Wave of awful lightheadedness came in spurts, but have NEVER reacted to any other vaccine like this, I convinced myself it must be low blood sugar, even though I tested fine before I left.  I was not nervous, and was in fact, excited to get this vaccine.   After 15 minutes, we leave, grab a bite to eat.  The lightheadedness came in waves and just didn't stop. An hour after, I started sweating and my heart was  switching between what seem like rapid pulse to pounding heartbeat, to the point I could hear it in my ears and when I laid down, it felt like my veins vibrated.  Around 5:30, a friend took me to the ER.  Having had to wait a while, thankfully by the times my vitals were took, everything looked normal.  Was told it was a panic attack and to get the second vaccine. That makes no sense, as I was not anxious and this was a very physical reaction.
HYPOTENSION 11/20/2021 SYNCOPE  HYPOTENSION 11/20/2021 ATRIAL FIBRILLATION, UNSPECIFIED  HYPOTENSION 11/20/2021 ATRIAL FIBRILLATION W RAPID VENTRICULAR RESPONSE  HYPOTENSION 11/20/2021 ANGINA, UNSPECIFIED  HYPOTENSION 11/20/2021 ACUTE NON ST ELEVATION MI
rush looked like hives; She was very tired; She was very sored; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (rush looked like hives), FATIGUE (She was very tired) and MYALGIA (She was very sored) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 3004668) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer (Batch: EL0739) on 03-Feb-2021 and Pfizer (Batch: AR1749) on 14-Apr-2021. Past adverse reactions to the above products included No adverse event with Pfizer and Pfizer.    On 08-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Nov-2021, the patient experienced URTICARIA (rush looked like hives), FATIGUE (She was very tired) and MYALGIA (She was very sored). At the time of the report, URTICARIA (rush looked like hives), FATIGUE (She was very tired) and MYALGIA (She was very sored) outcome was unknown.            Patient was healthy does not take any concomitant medication.  Treatment medication include Antihistamine.; Sender's Comments: This case concerns a female patient with unknown age with no reported medical history, vaccinated first two doses with Pfizer Covid 19 vaccine , who experienced non-serious , unexpected event of urticaria and expected events of myalgia and fatigue which occurred on the night after vaccination with the 3rd dose ( booster dose ) using mRNA-1273 vaccine ( Moderna Covid 19 Vaccine ) . The re-challenge for this case is not applicable since the events occurred during the  third dose ( booster dose ) and no additional doses will be given and also the outcome of the events is unknown. The benefit -risk relationship of mRNA -1273 ( Moderna Covid 19 Vaccine) is not affected by this report.
Have written to Health dept no answer-they must be busy. First shot resulted in very sore upper arm 1.5 days, no other effects. Clean injection into deltoid muscle bulk. Second shot, injection shot extremely high above main muscle bulk of the deltoid into area of supraspinatus tendon one finger below acromial shelf. First shot, two sensations: initial puncture then injection. Shot 2 one huge painful bump met with resistance in my tissue.  Also Shot 2 not one response except mild fatigue still today, but no pain in upper arm unless I pressed specifically into injection site itself.  WAS THIS VARIATION IN INJECTION SITE ACCEPTABLE? WAS IT OK TO DO INJECTION SO VERY HIGH UP? Secondly, had a wonderful, professional nurse, but I question the practice of retrieving a dose for me that comprised of doses left over at bottom(s) of other vial(s). We had a new vial in the office where I was, but she left and came back with a syringe already full, saying that it was important to use up every drop. At first I agreed, but now I question this practice and just want to make sure I don't need to come back for another second dose. Are there no substrates that would settle out of the solution as the vial gets depleted of everything except only a bit of fluid left in it? Is retrieving every last drop from each vial and putting them together to make a dose acceptable practice? if not, from the Pfizer standpoint, then I should get another dose? I am a pediatric physical therapists working within 1-2 feet a children's faces at all times and transmissibility is a real issue both ways in my job.  I truly do not want o become a Covid victim. please let me know if both the injection site and the method b y which my dose was put together is acceptable in the eyes of Pfizer. Thank you.
Patient contracted COVID after being fully vaccinated.  No booster Asymptomatic, was tested due to being hospitalized for other concerns.
This spontaneous report was received from a medical assistant via a field employee regarding an adult (reported as some age within his 20's, exact age not known), male patient. No information about medical history, drug reactions and allergies was specified. On an unknown date in approximately May 2014 (reported as about a month ago), the patient was vaccinated with PNEUMOVAX23 (dose not reported) vial, subcutaneously. No concomitant medications were reported. On an unknown date the patient developed swelling at the injection site and swelling continued to the patient's elbow of the arm injection was given. The field employee also reported that the medical assistant reported to her that this patient sought medical attention, had to go to emergency room because of this (it is not know whether the patient stayed overnight and the hospital name is unspecified). There was no product quality complaint with PNEUMOVAX23. The outcome of the event is unknown. The causality of the event was not specified by the reporter.  Additional information has been requested.
Chills , headaches , soreness in arm , body aches , body sweating and joint pain .